NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

thermoo, as you understand but many not, the mass and the mainstream Wall Street are usually dumb enough which is normal, and waiting for a trumpeter to blow the charge sound, which in this case is positive TLD.

And it is as it has been written on the wall, but the dumb masses would want something written in a news release which would explicitly say both primary and key secondary endpoints have been met.

Yes, the primary endpoint has been met pending news release based on the released blinded data and the best-of-care (standard-of-care) which has shown quite consistent and stable results in treating GMB, i.e., it has not changed much for a decade, let alone it would be abnormal enough to over-live DCVax-L treated patients; and the results of any ECAs known today.

When you have a blended arm of about 300 patients which has about 20% of all patients lived more than five years compared to about 5% of the standard-of-care (placebo) patients, it's a signal of efficacy for key secondary endpoints to be met statistically significantly as well.

As for what has delayed that trumpeter to blow the charge sound yet, the only logic conclusion is for certainty, additional home run, or simply a procedural issue.

I am a small fish compared to you guys. I think it's time for you guys (Linda's friendlies) to band together to protect the interests of this company in which we all have heavily invested.